Group 1 - The stock price of Kefu Medical (301087) closed at 54.39 yuan on February 5, 2026, with an increase of 1.49% and a turnover rate of 2.32% [1] - The trading volume was 45,100 hands, with a total transaction amount of 244 million yuan [1] - The net inflow of main funds was 1.1153 million yuan, accounting for 0.46% of the total transaction amount, while retail investors had a net outflow of 28.4653 million yuan, accounting for 11.64% [1] Group 2 - In the financing and securities lending data, the financing buy amounted to 21.9706 million yuan, with a net financing purchase of 7.5677 million yuan [2] - The stock had a financing and securities lending balance of 160 million yuan [2] - The company reported a main revenue of 2.398 billion yuan for the first three quarters of 2025, a year-on-year increase of 6.63%, and a net profit attributable to shareholders of 260 million yuan, up 3.3% year-on-year [3] Group 3 - In Q3 2025, the company achieved a single-quarter main revenue of 900.2 million yuan, a year-on-year increase of 30.72%, and a net profit of approximately 92.8298 million yuan, up 38.68% year-on-year [3] - The company’s gross profit margin was 53.35%, with a debt ratio of 27.37% [3] - Over the past 90 days, five institutions provided ratings for the stock, with four buy ratings and one hold rating, and the average target price was 54.92 yuan [3]
可孚医疗（301087）2月5日主力资金净买入111.53万元